Our leadership

We are a passionate team driven by our shared mission of making a significant positive impact on the treatment of childhood cancers. We are building an international consortium made up of drug discovery and development experts, clinical specialists, funders, impact investors and others to advance innovative science into effective and well tolerated therapies.

Joint management team

Our Joint Management Team brings together leaders from Cancer Research Horizons and LifeArc to oversee delivery of our shared strategy.

The team offers expertise across the full translational process. This includes drug discovery, scientific delivery, business development, and sourcing strategy.

They also leverage their expertise in programme management, patient engagement, and communications to increase our overall impact.

James Pickett

James Pickett

Co-lead

Cancer Research Horizons

Lone Friis

Lone Friis

Co-lead

LifeArc

Joint steering committee

The joint steering committee approves the sourcing strategy for potential projects, reviews proposed project applications, approves the inclusion of proposed projects into the consortium, oversees the progress of projects, the consortium’s budget and the consortium’s intellectual property, among other responsibilities. The group is made up of members from the core partners, Cancer Research Horizons, LifeArc and Great Ormond Street Hospital Charity (GOSH Charity).

Alex Bonner

Alex Bonner

Head of Grant Funding

GOSH Charity

Iain Foulkes

Iain Foulkes

Chief Executive Officer | Executive Director of Research and Innovation

Cancer Research Horizons | Cancer Research UK

Tony Hickson

Tony Hickson

Executive leadership / Chief Business Officer

C-Further / Cancer Research Horizons

Wendy Jacquemet-Ross

Wendy Jacquemet-Ross

Head of Partnerships, Childhood Cancer

LifeArc

George Orphanides

George Orphanides

Chief Scientific Officer

LifeArc

Aoife Regan

Aoife Regan

Director of Charitable Programmes and Impact

GOSH Charity

Hamish Ryder

Hamish Ryder

CEO, Therapeutic Innovation

Cancer Research Horizons

Samuel C. Blackman

Samuel C. Blackman

Member

Google Ventures

Alison Maloney

Alison Maloney

Chair

Dark Blue Therapeutics

Frank Mussai

Frank Mussai

Member

Roche/Birmingham Children’s Hospital

Andy Pearson

Andy Pearson

Member

Childhood cancer consultant

Sarah Tasian

Sarah Tasian

Member

Children's Hospital of Philadelphia

We’re looking for innovative research, new partners, funders and impact investors.